Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2023-07-17 2023-08-01 198817
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2019-05-07 2019-05-07 83270
SANDOZ RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2022-09-27 2022-10-26 170340
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2023-12-04 2023-12-20 212457
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2019-02-18 2019-03-05 76147
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2022-11-16 2022-11-29 174993
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2023-05-08 2023-05-25 192014
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2026-03-23 2026-03-31 281159
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2023-03-27 2023-04-12 188067
SANDOZ RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2024-02-20 2024-06-04 219980
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2019-02-12 2019-05-07 75511
SANDOZ RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2023-11-06 2024-06-26 209224
SANDOZ RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2023-02-14 2023-03-03 184639
SANDOZ RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2022-11-02 2023-01-19 173384
SANDOZ RANITIDINE 300MG TABLET Resolved 2017-09-07 2017-11-06 21334
SANDOZ RANITIDINE 150MG TABLET Resolved 2019-09-10 2023-11-17 93419
SANDOZ RANITIDINE 150MG TABLET Resolved 2019-09-10 2023-11-17 93422
SANDOZ RANITIDINE 300MG TABLET Resolved 2019-09-10 2023-11-17 93425
SANDOZ REPAGLINIDE 2MG TABLET Resolved 2021-03-22 2021-05-03 136067
SANDOZ REPAGLINIDE 1MG TABLET Resolved 2021-04-12 2021-05-03 137318
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136